Baltimore -- U.S. scientists said cancer stem cells for multiple myeloma make the bone marrow cancer resistant to chemotherapy and other treatments.
The finding by the Johns Hopkins Kimmel Cancer Center, published in the journal Cancer Research, may explain why the disease is so hard to treat, the university said Friday in a release.
Johns Hopkins scientists said researchers need to look for treatments that overcome the cells' drug resistance.
"Nature made normal stem cells very hearty for a reason, namely to survive and help repair damaged tissues and organs after injury or illness," lead investigator Dr. William Matsui said. "To us, it makes sense that the same processes that protect normal stem cells also exist in cancer stem cells to make them resistant to chemotherapy."
Disclaimer: The views and investment tips expressed by investment experts on themoneytimes.com are their own, and not that of the website or its management. TheMoneyTimes advises users to check with certified experts before taking any investment decision.
Recent comments
1 day 5 hours ago
1 day 12 hours ago
1 day 12 hours ago
1 day 15 hours ago
1 day 15 hours ago
2 days 9 hours ago
2 days 22 hours ago
4 days 6 hours ago
1 week 1 day ago
1 week 1 day ago